Started in 1996, Galderma South Africa celebrates 13 years of existence in the country as a wholly owned subsidiary and is ranked by IMS as no 3 in Dermatology.
The current focus is on prescription medications for both Dermatologists and General Practitioners. The product portfolio is dominated by treatments for acne for which Galderma is market leader. The largest brands within the Galderma portfolio include Differin® and Tetralysal®. The cosmetic range (Cetaphil® cleansers and moisturizers, Nutraderm® and Nutraplus®),
has been specifically formulated to be gentle and provide support for patients using any doctor’s prescription treatments. Benzac®, Loceryl® Nail Lacquer, Retacnyl®, Rozex® and Metvix®, completes the line-up.
Galderma employs 28 members of staff in the South African Affiliate, dedicated to the core business of Sales and Marketing, with Regulatory and Finance support. Many other noncore services such as local manufacturing and distribution are outsourced to local BEE partners.
Galderma works closely with the Dermatological Society of SA, and have set up a Dermatology Ethnic Working Group, to share information on ethnic skins, facilitate skills transfer, and assist with research through a specific Study Grant allocated to studying of black skins. The company also sponsors the official Dermatology Society website, which has a closed section for Medical Professionals, plus an open section for the public to use. Some practices used by our population still today can cause irreversible damage of the skin and the Dermatologists are really concerned about educating the general population. Through this website we are assisting them in reaching many consumers with the correct information about their skin care.
Galderma South Africa has been acclaimed as the market leader in Dermatology by both Dermatologists and GP’s regarding superior service and expertise on which the company prides itself and we remain committed to Dermatologists, GP’s, Pharmacists and their patients in the future.